July 16, 2020

Pliant Therapeutics Inc.

As a biopharmaceutical clinical company, Pliant Therapeutics Inc. (NASDAQ: PLRX at https://www.webull.com/quote/nasdaq-plrx ) targets various keys related to the biological pathways. It has been in existence since 2015, with its headquarters located in South San Francisco in California. The clinical company majorly focuses on fibrotic diseases or those diseases related to the chest and difficulty in breathing. The solutions or medical treatments provided by them help to sustain a good